Asia Pacific Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
The Asia Pacific dry eye products market was valued at US$ 1,101.46 million in 2023 and is expected to reach US$ 1,641.84 million by 2031; it is estimated to register a CAGR of 5.1% from 2023 to 2031.
Increasing Initiatives for Eye Care Awareness Boost Asia Pacific Dry Eye Products Market
In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. For instance, as a part of the Avoidable Blindness Program (ABP) (launched in 2021), Novartis worked with its partners across Sub-Saharan Africa and Southeast Asia to access to its eye care products in 2022. ABP focuses on moderate to severe vision damage caused by glaucoma and retinal conditions that are responsible for a large proportion of preventable blindness.
The International Agency for the Prevention of Blindness (IAPB) launched the global campaign named “Love Your Eyes” in 2022 to raise awareness of the socioeconomic importance of eye health. The campaign calls upon governments and global institutions to support eye health. The IAPB emphasizes programs and initiatives in India and the world, which promptly focus on offering accessible, available, and affordable eye care. The “Love Your Eyes” program also calls for regulation changes and funding to make eye care accessible, available, and affordable by 2030.
In December 2022, Research to Prevent Blindness selected the John A. Moran Eye Center at the University of Utah for the unlimited annual grant of US$ 115,000 to support eye research. As of December 2021, the National Institutes of Health (NIH) supported a partnership between Aravind Eye Hospital (India) and Kellogg Eye Center to develop a clinical research training program for eyecare professionals. As a part of this initiative, the NIH awarded US$ 1.1 million to support training programs in Ann Arbor (US) and offered seed funding for the participants. In addition, the India-US Collaborative Vision Research Program 2020 focuses on advancing science and technology to understand, prevent, and treat blinding visual disorders, eye diseases, and associated complications. The Indian Department of Biotechnology and the US National Eye Institute funded this research program.
Thus, increasing funds for eyecare research and rising initiatives to spread awareness about eye care are likely to create new opportunities in the dry eye product market in the coming years.
Asia Pacific Dry Eye Products Market Overview
The Asia Pacific dry eye products market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The factors that are likely to contribute to the market growth in this region include the increasing incidence of DED among young people due to prolonged usage of computers, growing government support for eye health, and ongoing developments in ophthalmic solutions. According to NIH, in China, ~20–30% of people are diagnosed with dry eye conditions every year. The dry eye products market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. Novaliq has established a strategic cooperation with Jiangsu Hengrui Pharmaceuticals to manufacture, develop, and commercialize NOV03 for the treatment of dry eye disease. In December 2021, Hengrui obtained positive outcomes from the critical Phase 3 clinical trial of SHR8058 (NOV03) for the treatment of dry eye disease linked with meibomian gland dysfunction; the trial was conducted at 17 sites across China. The Chinese firm is expected to distribute these products across China and Southeast Asia.
Asia Pacific Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Dry Eye Products Market Segmentation
The Asia Pacific dry eye products market is categorized into product, dosage form, type, distribution channel, and country.
Based on product, the Asia Pacific dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest Asia Pacific dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.
In terms of dosage form, the Asia Pacific dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest Asia Pacific dry eye products market share in 2023.
By type, the Asia Pacific dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger Asia Pacific dry eye products market share in 2023.
Based on distribution channel, the Asia Pacific dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest Asia Pacific dry eye products market share in 2023.
Based on country, the Asia Pacific dry eye products market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dry eye products market share in 2023.
Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG are some of the leading companies operating in the Asia Pacific dry eye products market.
Increasing Initiatives for Eye Care Awareness Boost Asia Pacific Dry Eye Products Market
In recent years, various initiatives have been taken to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. For instance, as a part of the Avoidable Blindness Program (ABP) (launched in 2021), Novartis worked with its partners across Sub-Saharan Africa and Southeast Asia to access to its eye care products in 2022. ABP focuses on moderate to severe vision damage caused by glaucoma and retinal conditions that are responsible for a large proportion of preventable blindness.
The International Agency for the Prevention of Blindness (IAPB) launched the global campaign named “Love Your Eyes” in 2022 to raise awareness of the socioeconomic importance of eye health. The campaign calls upon governments and global institutions to support eye health. The IAPB emphasizes programs and initiatives in India and the world, which promptly focus on offering accessible, available, and affordable eye care. The “Love Your Eyes” program also calls for regulation changes and funding to make eye care accessible, available, and affordable by 2030.
In December 2022, Research to Prevent Blindness selected the John A. Moran Eye Center at the University of Utah for the unlimited annual grant of US$ 115,000 to support eye research. As of December 2021, the National Institutes of Health (NIH) supported a partnership between Aravind Eye Hospital (India) and Kellogg Eye Center to develop a clinical research training program for eyecare professionals. As a part of this initiative, the NIH awarded US$ 1.1 million to support training programs in Ann Arbor (US) and offered seed funding for the participants. In addition, the India-US Collaborative Vision Research Program 2020 focuses on advancing science and technology to understand, prevent, and treat blinding visual disorders, eye diseases, and associated complications. The Indian Department of Biotechnology and the US National Eye Institute funded this research program.
Thus, increasing funds for eyecare research and rising initiatives to spread awareness about eye care are likely to create new opportunities in the dry eye product market in the coming years.
Asia Pacific Dry Eye Products Market Overview
The Asia Pacific dry eye products market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The factors that are likely to contribute to the market growth in this region include the increasing incidence of DED among young people due to prolonged usage of computers, growing government support for eye health, and ongoing developments in ophthalmic solutions. According to NIH, in China, ~20–30% of people are diagnosed with dry eye conditions every year. The dry eye products market in China is quite competitive, with the presence of both domestic and international pharmaceutical companies. Novaliq has established a strategic cooperation with Jiangsu Hengrui Pharmaceuticals to manufacture, develop, and commercialize NOV03 for the treatment of dry eye disease. In December 2021, Hengrui obtained positive outcomes from the critical Phase 3 clinical trial of SHR8058 (NOV03) for the treatment of dry eye disease linked with meibomian gland dysfunction; the trial was conducted at 17 sites across China. The Chinese firm is expected to distribute these products across China and Southeast Asia.
Asia Pacific Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Dry Eye Products Market Segmentation
The Asia Pacific dry eye products market is categorized into product, dosage form, type, distribution channel, and country.
Based on product, the Asia Pacific dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest Asia Pacific dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.
In terms of dosage form, the Asia Pacific dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest Asia Pacific dry eye products market share in 2023.
By type, the Asia Pacific dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger Asia Pacific dry eye products market share in 2023.
Based on distribution channel, the Asia Pacific dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest Asia Pacific dry eye products market share in 2023.
Based on country, the Asia Pacific dry eye products market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dry eye products market share in 2023.
Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG are some of the leading companies operating in the Asia Pacific dry eye products market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC DRY EYE PRODUCTS MARKET – KEY MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Rising Prevalence of Dry Eye
4.1.2 Upsurge in Geriatric Population
4.2 Market Restraints
4.2.1 Side Effects of Eye Drops and Product Recalls
4.3 Market Opportunities
4.3.1 Increasing Initiatives for Eye Care Awareness
4.4 Future Trends
4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.5 Impact of Drivers and Restraints:
5. DRY EYE PRODUCTS MARKET – ASIA PACIFIC MARKET ANALYSIS
5.1 Asia Pacific Dry Eye Products Market Revenue (US$ Million), 2021–2031
6. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY PRODUCT
6.1 Overview
6.2 Artificial Tears
6.2.1 Overview
6.2.2 Artificial Tears: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
6.3.1 Overview
6.3.2 Anti-Inflammatory Drugs: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
6.4 Punctal Plugs
6.4.1 Overview
6.4.2 Punctal Plugs: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.4.2.1 Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
6.5 Secretagogues
6.5.1 Overview
6.5.2 Secretagogues: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
6.6.1 Overview
6.6.2 Oral Omega Supplements: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY DOSAGE FORM
7.1 Overview
7.2 Eye Drops
7.2.1 Overview
7.2.2 Eye Drops: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
7.3.1 Overview
7.3.2 Gels: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
7.4.1 Overview
7.4.2 Capsules and Tablets: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY TYPE
8.1 Overview
8.2 OTC
8.2.1 Overview
8.2.2 OTC: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
8.3.1 Overview
8.3.2 Prescription: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
9.1 Overview
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10. ASIA PACIFIC DRY EYE PRODUCTS MARKET – COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific: Dry Eye Products Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 China: Dry Eye Products Market Breakdown, by Product
10.1.1.1.1.1 China: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.1.1.2 China: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.1.2 China: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.1.3 China: Dry Eye Products Market Breakdown, by Type
10.1.1.1.4 China: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.2 Japan: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Japan: Dry Eye Products Market Breakdown, by Product
10.1.1.2.3.1 Japan: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.2.3.2 Japan: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.2.4 Japan: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.2.5 Japan: Dry Eye Products Market Breakdown, by Type
10.1.1.2.6 Japan: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.3 India: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 India: Dry Eye Products Market Breakdown, by Product
10.1.1.3.3.1 India: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.3.3.2 India: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.3.4 India: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.3.5 India: Dry Eye Products Market Breakdown, by Type
10.1.1.3.6 India: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.4 Australia: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.3 Australia: Dry Eye Products Market Breakdown, by Product
10.1.1.4.3.1 Australia: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.4.3.2 Australia: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.4.4 Australia: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.4.5 Australia: Dry Eye Products Market Breakdown, by Type
10.1.1.4.6 Australia: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.5 South Korea: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.5.3 South Korea: Dry Eye Products Market Breakdown, by Product
10.1.1.5.3.1 South Korea: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.5.3.2 South Korea: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.5.4 South Korea: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.5.5 South Korea: Dry Eye Products Market Breakdown, by Type
10.1.1.5.6 South Korea: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.6 Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.6.3 Rest of APAC: Dry Eye Products Market Breakdown, by Product
10.1.1.6.3.1 Rest of APAC: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.6.3.2 Rest of APAC: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.6.4 Rest of APAC: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.6.5 Rest of APAC: Dry Eye Products Market Breakdown, by Type
10.1.1.6.6 Rest of APAC: Dry Eye Products Market Breakdown, by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Santen Pharmaceutical Co Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 OASIS Medical
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 OCuSOFT Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AbbVie Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Prestige Consumer Healthcare Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Farmigea SpA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Alcon AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC DRY EYE PRODUCTS MARKET – KEY MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Rising Prevalence of Dry Eye
4.1.2 Upsurge in Geriatric Population
4.2 Market Restraints
4.2.1 Side Effects of Eye Drops and Product Recalls
4.3 Market Opportunities
4.3.1 Increasing Initiatives for Eye Care Awareness
4.4 Future Trends
4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
4.5 Impact of Drivers and Restraints:
5. DRY EYE PRODUCTS MARKET – ASIA PACIFIC MARKET ANALYSIS
5.1 Asia Pacific Dry Eye Products Market Revenue (US$ Million), 2021–2031
6. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY PRODUCT
6.1 Overview
6.2 Artificial Tears
6.2.1 Overview
6.2.2 Artificial Tears: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Anti-Inflammatory Drugs
6.3.1 Overview
6.3.2 Anti-Inflammatory Drugs: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.3.2.1 Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Anti-inflammatory Drugs
6.4 Punctal Plugs
6.4.1 Overview
6.4.2 Punctal Plugs: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.4.2.1 Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million) – by Punctal Plugs
6.5 Secretagogues
6.5.1 Overview
6.5.2 Secretagogues: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Oral Omega Supplements
6.6.1 Overview
6.6.2 Oral Omega Supplements: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY DOSAGE FORM
7.1 Overview
7.2 Eye Drops
7.2.1 Overview
7.2.2 Eye Drops: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Gels
7.3.1 Overview
7.3.2 Gels: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Capsules and Tablets
7.4.1 Overview
7.4.2 Capsules and Tablets: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY TYPE
8.1 Overview
8.2 OTC
8.2.1 Overview
8.2.2 OTC: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Prescription
8.3.1 Overview
8.3.2 Prescription: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9. ASIA PACIFIC DRY EYE PRODUCTS MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
9.1 Overview
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Asia Pacific Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10. ASIA PACIFIC DRY EYE PRODUCTS MARKET – COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific: Dry Eye Products Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 China: Dry Eye Products Market Breakdown, by Product
10.1.1.1.1.1 China: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.1.1.2 China: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.1.2 China: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.1.3 China: Dry Eye Products Market Breakdown, by Type
10.1.1.1.4 China: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.2 Japan: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Japan: Dry Eye Products Market Breakdown, by Product
10.1.1.2.3.1 Japan: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.2.3.2 Japan: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.2.4 Japan: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.2.5 Japan: Dry Eye Products Market Breakdown, by Type
10.1.1.2.6 Japan: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.3 India: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 India: Dry Eye Products Market Breakdown, by Product
10.1.1.3.3.1 India: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.3.3.2 India: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.3.4 India: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.3.5 India: Dry Eye Products Market Breakdown, by Type
10.1.1.3.6 India: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.4 Australia: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.4.3 Australia: Dry Eye Products Market Breakdown, by Product
10.1.1.4.3.1 Australia: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.4.3.2 Australia: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.4.4 Australia: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.4.5 Australia: Dry Eye Products Market Breakdown, by Type
10.1.1.4.6 Australia: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.5 South Korea: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.5.3 South Korea: Dry Eye Products Market Breakdown, by Product
10.1.1.5.3.1 South Korea: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.5.3.2 South Korea: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.5.4 South Korea: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.5.5 South Korea: Dry Eye Products Market Breakdown, by Type
10.1.1.5.6 South Korea: Dry Eye Products Market Breakdown, by Distribution Channel
10.1.1.6 Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.6.3 Rest of APAC: Dry Eye Products Market Breakdown, by Product
10.1.1.6.3.1 Rest of APAC: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
10.1.1.6.3.2 Rest of APAC: Dry Eye Products Market Breakdown, by Punctal Plugs
10.1.1.6.4 Rest of APAC: Dry Eye Products Market Breakdown, by Dosage Form
10.1.1.6.5 Rest of APAC: Dry Eye Products Market Breakdown, by Type
10.1.1.6.6 Rest of APAC: Dry Eye Products Market Breakdown, by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Dry Eye Products Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Santen Pharmaceutical Co Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 OASIS Medical
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 URSAPHARM Arzneimittel GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rohto Pharmaceutical Co Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 OCuSOFT Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bausch Health Companies Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AbbVie Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Prestige Consumer Healthcare Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Farmigea SpA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Alcon AG
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
